The C19orf12 gene, associated with the condition known as Spastic Paraplegia 43 (SPG43), is a critical genetic marker for diagnosing this rare hereditary spastic paraplegia. The SPG43 genetic test specifically targets mutations within the C19orf12 gene to confirm the diagnosis, allowing for appropriate management and genetic counseling. DNA Labs UAE offers this specialized genetic test for individuals suspected of having SPG43. The test is priced at 4400 AED, reflecting the advanced molecular techniques employed to accurately identify mutations in the C19orf12 gene. This test is crucial for families seeking answers to genetic conditions, providing them with the necessary information to understand their genetic health better.
The GJC2 Gene SPG44 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the GJC2 gene, which are associated with Spastic Paraplegia 44 (SPG44), a rare form of hereditary spastic paraplegia. This condition is characterized by progressive weakness and spasticity, primarily in the lower limbs, and can lead to severe mobility issues. The test involves analyzing the patient's DNA to detect specific genetic alterations in the GJC2 gene that are known to cause SPG44.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test is crucial for individuals with a family history of hereditary spastic paraplegia or those exhibiting symptoms, providing them with a definitive diagnosis. Early detection through this genetic test can significantly aid in managing the condition, allowing for appropriate therapeutic interventions and genetic counseling for affected families.
The cost of the GJC2 Gene SPG44 Genetic Test at DNA Labs UAE is 4400 AED, reflecting the comprehensive analysis and detailed insights it provides into the patient's genetic makeup regarding SPG44. This investment in health can be invaluable for affected individuals and their families, offering clarity on the condition and guidance on how to best manage it.
The NT5C2 Gene SPG45 Genetic Test is a specialized diagnostic tool designed to identify mutations in the NT5C2 gene, which are associated with Spastic Paraplegia 45 (SPG45), a rare form of hereditary spastic paraplegia. This condition is characterized by progressive stiffness and contraction in the lower limbs, leading to mobility challenges and other neurological symptoms. By analyzing the patient's DNA, this test can confirm the presence of genetic alterations in the NT5C2 gene, providing crucial information for accurate diagnosis, management, and genetic counseling of affected individuals and their families.
The test is conducted at DNA Labs UAE, a leading facility in genetic diagnostics that employs cutting-edge technology and methodologies to ensure high accuracy and reliability of results. The cost of the NT5C2 Gene SPG45 Genetic Test is 4400 AED, reflecting the specialized nature of the analysis and the comprehensive insights it offers into the patient's genetic makeup. This information is invaluable for devising personalized treatment plans and understanding the inheritance patterns, potentially benefiting other family members.
The KCNQ3 Gene Seizures Benign Neonatal Type 2 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the KCNQ3 gene, which are associated with Benign Neonatal Seizures Type 2 (BNST2). This condition is characterized by the onset of seizures within the first days or weeks of life, which usually resolve spontaneously within the first year. Although the seizures are generally not harmful to the infant's long-term development, early and accurate diagnosis is crucial for appropriate management and to alleviate parental concerns.
The test involves analyzing the patient's DNA to detect any genetic alterations in the KCNQ3 gene, which plays a critical role in the proper functioning of nerve cells in the brain. Mutations in this gene can disrupt the normal flow of potassium ions in neurons, leading to the development of seizures.
Priced at 4400 AED, the test is conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities and high standards of accuracy and reliability. This test is particularly valuable for families with a history of BNST2, as it can provide essential information for early intervention strategies and help in understanding the genetic predisposition to the condition within the family.
The KCNJ10 Gene SESAME Syndrome Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the KCNJ10 gene, which are associated with SESAME syndrome. SESAME syndrome, an acronym for Seizures, Sensorineural deafness, Ataxia, Mental retardation, and Electrolyte imbalance, is a rare genetic disorder. The KCNJ10 gene plays a critical role in the proper functioning of potassium channels in the brain, inner ear, and kidneys, and mutations in this gene can disrupt these processes, leading to the symptoms observed in SESAME syndrome.
This genetic test is crucial for early detection and management of the syndrome, offering insights into the specific genetic alterations present in an individual. With a test cost of 4400 AED, DNA Labs UAE utilizes advanced genetic sequencing technologies to provide accurate and reliable results. Early diagnosis through the KCNJ10 Gene SESAME Syndrome Genetic Test can significantly impact the management and treatment options for affected individuals, offering a path towards a better quality of life.
The SLC17A5 gene Sialuria Finnish Type genetic test is a specialized diagnostic tool designed to identify mutations in the SLC17A5 gene, which are responsible for causing Sialuria Finnish Type, a rare genetic disorder. This condition is characterized by an excess of free sialic acid in the body, leading to various symptoms such as developmental delay, coarse facial features, and organomegaly. The test involves analyzing the patient's DNA to detect mutations in the SLC17A5 gene, providing crucial information for diagnosis, management, and genetic counseling of affected individuals and their families.
Performed at DNA Labs UAE, a leading facility in genetic testing, the cost of the SLC17A5 gene Sialuria Finnish Type genetic test is 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals, ensuring accurate and reliable test results. This test is an important resource for families with a history of Sialuria Finnish Type, offering them the opportunity for early diagnosis and intervention.
The GPC3 gene test for Simpson-Golabi-Behmel Syndrome Type 1 is a specialized genetic screening offered by DNA Labs UAE. This test is designed to identify mutations in the GPC3 gene, which are linked to the development of Simpson-Golabi-Behmel Syndrome Type 1 (SGBS1), a rare genetic disorder characterized by pre- and postnatal overgrowth, distinctive facial features, and a variety of organ abnormalities. The condition is primarily seen in males and can have variable expressivity. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of specific genetic mutations associated with SGBS1.
The cost of the GPC3 gene test is 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to interpret the results. Conducting the test at DNA Labs UAE ensures that patients receive accurate and reliable results, as the lab is equipped with state-of-the-art genetic testing technology and staffed by professionals with expertise in genetic disorders. This test is crucial for families seeking a diagnosis for symptoms consistent with Simpson-Golabi-Behmel Syndrome Type 1, as it provides essential information for managing the condition and understanding the risk of recurrence in future pregnancies.
The ALDH3A2 gene Sjogren-Larsson Syndrome genetic test is a diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the ALDH3A2 gene that are associated with Sjogren-Larsson Syndrome (SLS). Sjogren-Larsson Syndrome is a rare, inherited neurocutaneous disorder characterized by ichthyosis (scaly skin), intellectual disability, and spastic diplegia or quadriplegia. Mutations in the ALDH3A2 gene disrupt the metabolism of fatty alcohols, leading to the accumulation of toxic substances in the body, which in turn cause the symptoms of the syndrome.
This genetic test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the ALDH3A2 gene that are known to cause SLS. Identifying these mutations can confirm a diagnosis of Sjogren-Larsson Syndrome, allowing for early intervention, management of symptoms, and genetic counseling for affected families.
The cost of the ALDH3A2 gene Sjogren-Larsson Syndrome genetic test at DNA Labs UAE is 4400 AED. This price may cover the test itself, the expertise of the medical professionals conducting and analyzing the test, and any post-test counseling that may be necessary based on the results. It's important for potential patients to check if additional costs may apply and if their insurance may cover part of the cost. The test provides crucial information for affected individuals and their families and represents a significant step in managing the condition effectively.
The ARHGEF10 gene is implicated in the development and function of the peripheral nervous system, specifically in the myelination process of peripheral nerves. Mutations in this gene have been linked to slowed nerve conduction velocity, a condition that affects the speed at which electrical signals are transmitted through the nerves. This can lead to a range of neurological symptoms, including muscle weakness and sensory disturbances.
To diagnose conditions related to mutations in the ARHGEF10 gene, DNA Labs UAE offers a specialized genetic test. This test is designed to identify alterations in the ARHGEF10 gene that are associated with autosomal dominant inheritance patterns of slowed nerve conduction velocity. The autosomal dominant nature of the condition means that only one copy of the mutated gene, inherited from either parent, is sufficient to cause the disorder.
The test offered by DNA Labs UAE involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing it for specific mutations in the ARHGEF10 gene. This test is crucial for individuals who exhibit symptoms of slowed nerve conduction or have a family history of the condition, as it can provide a definitive diagnosis and guide treatment and management strategies.
The cost of the ARHGEF10 gene test at DNA Labs UAE is 4400 AED. This investment in genetic testing can be invaluable for affected individuals and their families, offering insights into the genetic basis of their condition and informing decisions about care and support.
The RAI1 Gene Smith-Magenis Syndrome Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the RAI1 gene, which are associated with Smith-Magenis Syndrome (SMS). SMS is a developmental disorder characterized by distinctive facial features, developmental delay, behavioral problems, and sleep disturbances. The test plays a crucial role in the early detection and management of SMS, offering insights into potential interventions and support for affected individuals.
This genetic test involves analyzing the patient's DNA to look for specific alterations in the RAI1 gene that are known to cause Smith-Magenis Syndrome. Early diagnosis through this test can significantly benefit patients and families by providing them with a clear understanding of the condition, enabling access to targeted therapies, and support services, and facilitating informed decision-making regarding care and management.
At DNA Labs UAE, the RAI1 Gene Smith-Magenis Syndrome Genetic Test is priced at 4400 AED. This cost includes the collection of a DNA sample, usually through a blood draw or cheek swab, and its subsequent analysis in the laboratory. The price reflects the comprehensive nature of the test, encompassing the expertise required for accurate interpretation of the results and the provision of detailed genetic counseling to discuss the findings. This test represents a vital resource for families seeking answers about Smith-Magenis Syndrome, offering hope and direction in navigating the challenges associated with the disorder.
